Hmong-language VISs
Out-of-date
The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version
of the following VISs.
You are
encouraged to distribute the up-to-date English-language
VIS at
the same time as the translation.
This VIS may be used
in place of individual VISs whenever any routine birth through 6-month
vaccine is administered, or when certain combination vaccines are used.
Read more.
These translations do not
contain the following CDC update:
- Multi-vaccine VIS update. An updated
interim edition of the pediatric multi-vaccine VIS, dated September
18, 2008, has been posted. It has been made consistent with the
recently updated rotavirus VIS by noting the availability of two
rotavirus vaccines in the "Routine Childhood Vaccines" section and
adding "irritability" to the mild problems listed for rotavirus in
the "Vaccine Risks" section. Otherwise, the VIS is identical to the
1/30/08 edition. Providers using the multi-vaccine VIS when
administering Rotarix should begin using the new edition now. When
Rotarix is not administered, the older edition may be used until
stocks are used up. (9/18/08)
This translation does not contain the
following CDC updates:
- Section 1: The
answer has been rewritten by CDC.
- Section 2: There
are now 2 doses; the first dose is 12-15 months and the second
dose is 4-6 years.
- CDC added information
on MMRV.
- The URL for Vaccine
Adverse Event Reporting System (VAERS) has changed to www.vaers.hhs.gov.
- The URL for the
National Vaccine Injury Compensation Programs has changed
to www.hrsa.gov/vaccincompensation.
These translations do not contain the
following CDC updates:
- On July 18, the CDC posted an interim
VIS for hepatitis B. There are minor changes throughout, but the main
purpose of the update is to emphasize the birth dose for all children.
- A final version will be developed.
These translations do not
contain the following CDC updates:
- Information was added about MMRV vaccine, tied to the
March 14 MMWR, regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR and
varicella vaccines given separately. Aside from two boxes containing
information about MMRV, both VISs are identical to the previous
editions.
- The new VISs should be used when MMRV is given; but the existing
stocks of the individual MMR and varicella VISs may be used when the
vaccines are given separately.
These translations do not contain the following
CDC updates:
- The CDC posted an updated interim PCV VIS on 12/9/08. The main
reason is to incorporate recent changes in recommendations for 2-4 year
olds, but there are other changes throughout as well. There are no
changes in contraindications or adverse events, but to prevent parents
from getting confused about the differences in indications (especially
when the vaccine is administered to 2-4 year olds) it would be best for
providers to start using the new version right away. Existing stocks CAN
still be used temporarily if immediately switching to the new version is
a problem.
You will be linked to the CDC website,
to download the Smallpox pre-vaccination information packet,
which includes the Smallpox VIS.
Please note: there are supplements that come with this VIS, but the
supplements have not been translated, just the VIS.
Thanks to
the Minnesota Department of Health and the California Department
of Health Services for their translations.This page was updated on
December 11, 2008 |
Immunization Action Coalition
IAC Home
